Home NDC 71894-200 ITVISMA
Product NDC 71894-200
11-digit product format 718940200
Labeler code 71894
Product ID 71894-200_ab2e1c6c-4f95-4243-9296-1734e0a30591
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name onasemnogene abeparvovec-brve
Dosage form INJECTION, SUSPENSION
Route INTRATHECAL
Labeler Novartis Gene Therapies, Inc.
Application BLA125856
Marketing category BLA
Marketing start 2025-11-24
Substance ONASEMNOGENE ABEPARVOVEC
Active strength 40000000000000 [arb'U]/mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ITVISMA ONASEMNOGENE ABEPARVOVEC-BRVE Novartis Innovative Technologies Inc. ab2e1c6c-4f95-4243-9296-1734e0a30591 2026-06-16 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA125856 ndc (product): 71894-200
Additional Listing Data#
Finished product Yes
Brand name base ITVISMA
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength ONASEMNOGENE ABEPARVOVEC 40000000000000 [arb'U]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination MLU3LU3EVV Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2727307 Internal RxNorm lookup 2727314 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71894-200-01 ITVISMA 3 mL in 1 VIAL, SINGLE-DOSE INJECTION, SUSPENSION 3 1 71894-200-02 ITVISMA 1 in 1 CARTON INJECTION, SUSPENSION 1 1
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125856 ITVISMA onasemnogene abeparvovec-brve 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 71894-200-01 71894020001 3 mL in 1 VIAL, SINGLE-DOSE 3 ml Historical 71894-200-02 71894020002 1 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01) 2025-11-24 No No Current